These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 33167975)
1. Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE). Samsom KG; Bosch LJW; Schipper LJ; Roepman P; de Bruijn E; Hoes LR; Riethorst I; Schoenmaker L; van der Kolk LE; Retèl VP; Frederix GWJ; Buffart TE; van der Hoeven JJM; Voest EE; Cuppen E; Monkhorst K; Meijer GA BMC Med Genomics; 2020 Nov; 13(1):169. PubMed ID: 33167975 [TBL] [Abstract][Full Text] [Related]
2. Early technology assessment of using whole genome sequencing in personalized oncology. Simons M; Van De Ven M; Coupé V; Joore M; IJzerman M; Koffijberg E; Frederix G; Uyl-De Groot C; Cuppen E; Van Harten W; Retèl V Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):343-351. PubMed ID: 33910430 [No Abstract] [Full Text] [Related]
3. Feasibility of whole-genome sequencing-based tumor diagnostics in routine pathology practice. Samsom KG; Schipper LJ; Roepman P; Bosch LJ; Lalezari F; Klompenhouwer EG; de Langen AJ; Buffart TE; Riethorst I; Schoenmaker L; Schout D; van der Noort V; van den Berg JG; de Bruijn E; van der Hoeven JJ; van Snellenberg H; van der Kolk LE; Cuppen E; Voest EE; Meijer GA; Monkhorst K J Pathol; 2022 Oct; 258(2):179-188. PubMed ID: 35792649 [TBL] [Abstract][Full Text] [Related]
4. Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice. Samsom KG; Bosch LJW; Schipper LJ; Schout D; Roepman P; Boelens MC; Lalezari F; Klompenhouwer EG; de Langen AJ; Buffart TE; van Linder BMH; van Deventer K; van den Burg K; Unmehopa U; Rosenberg EH; Koster R; Hogervorst FBL; van den Berg JG; Riethorst I; Schoenmaker L; van Beek D; de Bruijn E; van der Hoeven JJM; van Snellenberg H; van der Kolk LE; Cuppen E; Voest EE; Meijer GA; Monkhorst K Nat Protoc; 2024 Mar; 19(3):700-726. PubMed ID: 38092944 [TBL] [Abstract][Full Text] [Related]
5. Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study. van Opijnen MP; Broekman MLD; de Vos FYF; Cuppen E; van der Hoeven JJM; van Linde ME; Compter A; Beerepoot LV; van den Bent MJ; Vos MJ; Fiebrich HB; Koekkoek JAF; Hoeben A; Kho KH; Driessen CML; Jeltema HR; Robe PAJT; Maas SLN BMC Med Genomics; 2022 Nov; 15(1):233. PubMed ID: 36333718 [TBL] [Abstract][Full Text] [Related]
6. Analytical demands to use whole-genome sequencing in precision oncology. Meggendorfer M; Jobanputra V; Wrzeszczynski KO; Roepman P; de Bruijn E; Cuppen E; Buttner R; Caldas C; Grimmond S; Mullighan CG; Elemento O; Rosenquist R; Schuh A; Haferlach T Semin Cancer Biol; 2022 Sep; 84():16-22. PubMed ID: 34119643 [TBL] [Abstract][Full Text] [Related]
7. Whole genome sequencing in oncology: using scenario drafting to explore future developments. van de Ven M; Simons MJHG; Koffijberg H; Joore MA; IJzerman MJ; Retèl VP; van Harten WH BMC Cancer; 2021 May; 21(1):488. PubMed ID: 33933021 [TBL] [Abstract][Full Text] [Related]
8. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine. Paolillo C; Londin E; Fortina P Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004 [TBL] [Abstract][Full Text] [Related]
9. Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing. Pasmans CTB; Tops BBJ; Steeghs EMP; Coupé VMH; Grünberg K; de Jong EK; Schuuring EMD; Willems SM; Ligtenberg MJL; Retèl VP; van Snellenberg H; de Bruijn E; Cuppen E; Frederix GWJ Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):413-414. PubMed ID: 33852815 [No Abstract] [Full Text] [Related]
10. A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias. Berglund E; Barbany G; Orsmark-Pietras C; Fogelstrand L; Abrahamsson J; Golovleva I; Hallböök H; Höglund M; Lazarevic V; Levin LÅ; Nordlund J; Norèn-Nyström U; Palle J; Thangavelu T; Palmqvist L; Wirta V; Cavelier L; Fioretos T; Rosenquist R Front Med (Lausanne); 2022; 9():842507. PubMed ID: 35402448 [TBL] [Abstract][Full Text] [Related]
11. Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology. Rossen JWA; Friedrich AW; Moran-Gilad J; Clin Microbiol Infect; 2018 Apr; 24(4):355-360. PubMed ID: 29117578 [TBL] [Abstract][Full Text] [Related]
12. Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer. Simons MJHG; Retèl VP; Ramaekers BLT; Butter R; Mankor JM; Paats MS; Aerts JGJV; Mfumbilwa ZA; Roepman P; Coupé VMH; Uyl-de Groot CA; van Harten WH; Joore MA Pharmacoeconomics; 2021 Dec; 39(12):1429-1442. PubMed ID: 34405371 [TBL] [Abstract][Full Text] [Related]